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469 The European Normative framework on the involvement of
CF minors in clinical trials
W. Pinxten1, H. Nys1, K. Dierickx1. 1Centre for Biomedical Ethics and Law,
Leuven, Belgium
Background: During the past decades, important regulatory efforts have been made
to develop a harmonized normative framework facilitating the conduct of paediatric
clinical trials. Despite these efforts, a great variety in regulation continues to exist,
and various important ethical issues are not addressed within the legal framework.
Objectives: To study the difﬁculties and opportunities in the implementation of
European regulation in paediatric CF research practice.
Scope: The Declaration of Helsinki (1996 revision), the Convention on Human
Rights and Biomedicine (and the additional protocol on biomedical research), the
Clinical Trials Directive, and the draft EMEA-guideline on the ethical concerns for
clinical trials performed in children.
Methods: Comparative law methodology, literature study.
Results:
1. Regulatory interventions mainly focus on the harmonization of existing GCP-
guidelines and the development of a competitive research environment;
2. Despite far going harmonization efforts, contradictory provisions at the European
level still exist;
3. The considerable freedom physicians have in implementing the ethical concerns
and principles formulated in the legal framework, entails both dangers (e.g.
bias, interpretation difﬁculties) and opportunities (e.g. truly addressing ethical
concerns);
4. Although the informed consent conference is an excellent opportunity for
professionals, minors, and their parents to discuss ethical concerns in research
participation, the European legal framework hardly covers patient concerns other
than safety and protection. In addition, the heterogeneity of the paediatric public
is poorly addressed;
5. The European legal framework does not correct the varying economic interest
in paediatric clinical trials.
Supported by: EuroCareCF Coordination Action (FP6/LSHM-CT-2005–18932).
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Introduction: At our clinic we have a team of staff caring for 23 families (26
children) with CF. The team consists of, Consultant Paediatrician, Sp Registrar,
Specialist CF Nurse, Respiratory nurses, Dietician, Physiotherapist. In addition we
have ward, clinic, pharmacy and x-ray support staff all that have a special interest in
CF. We have a shared care system of service with Alder Hey Children’s Hospital,
Liverpool, UK. The views of patients and their carers are of utmost importance
within our service and indeed within the NHS.
A questionnaire was developed to assess the level of satisfaction our clients and
their families have of the care they receive within a DGH.
The aim: To allow the team to assess the need for change and improvement and
to ensure that any changes made were appropriate to the needs of the families we
care for.
Method: The survey was based on a ﬁve point Likert scale with additional room for
comments. 30 questionnaires containing 14 questions were posted out to families
and patients over the age of 13 years, with SAE included to ensure anonymity.
Results:We had a return rate of 66%. The results showed a high rate of satisfaction
with the services offered with 100% of returns showing either satisﬁed or very
satisﬁed with the overall quality of care. Questions included satisfaction with pro-
fessional services, clinic facilities, contact with staff and courtesy/privacy/dignity.
Comments received from clients also reﬂected the high satisfaction levels reported.
Conclusion: The results allowed the team to understand changes needed to improve
the service we offer and allowed the families we care for to express their views and
concerns.
471 ECORN-CF project in the Czech Republic: ﬁrst experiences
J. Brazova1, V. Vavrova1, A. Pickova1, L. Smolikova1, M. Macek Jr1. 1CF centre,
Charles Univ. 2nd Medical School and University Hospital Motol, Prague, Czech
Republic
ECORN-CF is a 36 month EU grant project (www.ecorn-cf.eu) with its major aim
being establishment of a model reference network for European CF centres. This
project should ease access to expert advice for CF patients, doctors, as well as
other CF team members, by implementation of a multilingual web-based service.
ECORN-CF should help to built and complete a European Consensus for care
for CF patients when and where it is necessary. We started with the Czech Rep.
website already in October 2007. After expected corrections at the very beginning,
our website is now working successfully. We have received 25 questions, so far. It is
surprising that about half of the questions are in Slovak and their spectrum is broad.
Patients, parents and even other CF team members were asking about CF basics –
like sweat chloride test, ABPA, Pseudomonas infection, atypical CF, adverse effects
of corticosteroids, inhalators, uridintriphosphate therapy, airway clearance vests,
having another baby, school attendance, social contributions etc. There were few
questions from students writing their thesis on CF related topics. It is not always
easy to answer a question and it is very useful to have the possibility to re-check
answer correctness by other CF experts and also discuss these at regular project
meetings. We advertised our project with the Czech CF lay organisation – CF Klub.
Public acceptance of the project is very good. However, we get corrections of
our answers after we had already posted them on the local website. We hope
that in future more interesting questions will arrive and that we will manage a
Slovak cooperating partner for many patients, parents and CF care team members
in Slovakia.
Supported by: ECORN-CF, IGA NR8458−5 and VZ 00064203.
472 CF Education for respiratory trainees in one UK region
S. Baird1, N. Sinnott1, A. Mohammad1, M.J. Ledson1, M.J. Walshaw1. 1Regional
Adult CF Unit, The Cardiothoracic Centre, Liverpool, United Kingdom
Introduction: In order to comply with EEC directives, specialist medical training in
the UK has been compressed to 5 years, and there is now little scope for providing
experience in sub specialist areas. This is of particular importance in CF, where
the numbers of patients are increasing and there are now more adults than children
with the disease. We surveyed respiratory trainees in one UK region (North West)
served by two large adult CF centres, to quantify current CF training practise and
also to canvass their opinion regarding the minimum acceptable amount.
Method: An anonymous survey of 27 respiratory trainees at a regional training
day.
Results: There was a wide variation in the amount of CF experience obtained. Four
trainees received none, and a further 4 had no formal secondment to a CF unit. Of
the remainder, one spent 2 weeks in a CF unit, sixteen 3 months, one 6 months,
and one a year. As regards their view of the minimum experience necessary, only
2 indicated no formal attachment, relying on teaching days and a course. Of the
remainder, twelve suggested 2 weeks in a CF unit, thirteen 3 months, and one 6
months. Only 9 indicated their training was adequate: 7 wanted more and 11 less
(all these spent at least 3 months in a CF unit).
Conclusion: This survey has shown that current CF training in one UK region is
variable, a pattern which is likely to be representative nationally. Trainees also had
diverse views as to the minimum acceptable amount. This survey lends weight to
the concept of a national organised training program for CF in the UK, to ensure
an adequate level of knowledge amongst general respiratory physicians for this
increasingly common disease.
